Active Ingredient: FLOTUFOLASTAT F-18 GALLIUM
Proprietary Name: POSLUMA
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 25ML (8-158mCi/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N216023
Product Number: 001
Approval Date: May 25, 2023
Applicant Holder Full Name: BLUE EARTH DIAGNOSTICS LTD
Marketing Status:
Prescription
Patent and Exclusivity Information
